Search filters

List of works by Adrian F Ochsenbein

A young man with sore throat and infection

scientific article published on May 17, 1997

Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial.

scientific article published on 23 November 2016

Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial

scientific article

Blocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cells

scientific article published on 4 February 2015

CD127+ innate lymphoid cells are dysregulated in treatment naïve acute myeloid leukemia patients at diagnosis

scientific article published on 20 February 2015

CD47 protein expression in acute myeloid leukemia: A tissue microarray-based analysis

scientific article published on 20 April 2015

CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML

scientific article published on 01 November 2019

CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.

scientific article published on 11 May 2017

CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia

scientific article published on 28 December 2016

CD8+ T cells expand stem and progenitor cells in favorable but not adverse risk acute myeloid leukemia

scientific article published on 15 March 2019

Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression

scientific article

Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).

scientific article published on 29 May 2014

Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials.

scientific article published on 18 April 2011

Dendritic cell-based immunotherapy for myeloid leukemias.

scientific article published on 31 December 2013

From "magic bullets" to specific cancer immunotherapy.

scientific article published on 23 January 2013

IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms

scientific article

IgD can largely substitute for loss of IgM function in B cells

scientific article published on June 25, 1998

Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

scientific article published on 11 August 2015

Long term survival after trimodal therapy in malignant pleural mesothelioma

scientific article published on October 25, 2012

Microbiota-derived compounds drive steady-state granulopoiesis via MyD88/TICAM signaling

scientific article

Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01)

scientific article published on 26 September 2018

Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial

scientific article published on 30 October 2015

Neutralizing antiviral antibody responses

scientific article published on January 1, 2001

OS07.2 Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the ARTE trial.

scientific article

Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07

scientific article published on May 18, 2012

Regulation of hematopoietic and leukemic stem cells by the immune system.

scientific article published on 04 July 2014

Regulation of lymphangiogenesis in the diaphragm by macrophages and VEGFR-3 signaling

scientific article published on 27 July 2016

Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers.

scientific article published on 12 November 2015

T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma

scientific article published on 21 September 2017

T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses

scientific article published on August 1, 1998

T-cell-secreted TNF-alpha induces emergency myelopoiesis and myeloid-derived suppressor cell-differentiation in cancer

scientific article published on 02 November 2018

TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance

scientific article published on 16 January 2014

TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis.

scientific article published on 20 October 2016

Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents

scientific article published on 29 June 2020

Treatment sequence in patients with neuroendocrine tumours: a nationwide multicentre, observational analysis of the Swiss neuroendocrine tumour registry

scientific article published on 15 January 2020

Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549

scientific article published on 27 December 2018

Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling.

scientific article published on July 2015

mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer

scientific article published on 31 August 2018